Page last updated: 2024-11-03

rimantadine and Diabetes Mellitus, Type 2

rimantadine has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Rimantadine: An RNA synthesis inhibitor that is used as an antiviral agent in the prophylaxis and treatment of influenza.

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, J1
Obando, D1
Liao, V1
Lifa, T1
Codd, R1

Reviews

1 review available for rimantadine and Diabetes Mellitus, Type 2

ArticleYear
The many faces of the adamantyl group in drug design.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:6

    Topics: Adamantane; Animals; Antimalarials; Diabetes Mellitus, Type 2; Drug Design; Humans; Hypoglycemic Age

2011